Abstract:Regulatory T (Treg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses1,2,3,4. Foxp3 operates as a late-acting differentiation factor controlling Treg cell homeostasis and function5, whereas the early Treg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors6,7,8,9,10. However, whether Foxo proteins act beyond the Treg-cell-commitment stage to control Treg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of Tregcell function. Treg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with Treg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of Treg cells. Genome-wide analysis of Foxo1 binding sites reveals ∼300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt–Foxo1 signalling module controls a novel genetic program indispensable for Treg cell function. The results of a series of genetic experiments indicate that Foxo1 has a pivotal, Foxp3-independent role controlling regulatory T-cell function. Foxo transcription factors are known to be involved in the control of immune homeostasis at least up to the regulatory T (Treg)-cell commitment stage. This paper reveals a crucial role for Foxo1 in the control of Treg-cell-dependent immune tolerance, independent of Foxo3. The authors propose that Treg cells co-opt the evolutionarily ancient Akt–Foxo1 signalling pathway to control a novel genetic program essential for Treg-cell function. This raises the possibility that manipulating the Akt–Foxo1 signalling pathway might offer a treatment for Treg-cell-associated immunological disorders.

Noc4L-Mediated Ribosome Biogenesis Controls Activation of Regulatory and Conventional T Cells.

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

Neuropilin-1 Identifies a New Subpopulation of TGF--Induced Foxp3<SUP>+</SUP> Regulatory T Cells With Potent Suppressive Function and Enhanced Stability During Inflammation

New Insights on Ox40 in the Control of T Cell Immunity and Immune Tolerance in Vivo

Lineage Tracking the Generation of T Regulatory Cells From Microbial Activated T Effector Cells in Naive Mice

Nutrient Mtorc1 Signaling Underpins Regulatory T Cell Control of Immune Tolerance

Transcriptional control of central T cell tolerance by NR4A family nuclear receptors

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

Nuclear receptor corepressor 1 controls regulatory T cell subset differentiation and effector function

Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

Immune Homeostasis Enforced by Co-Localized Effector and Regulatory T Cells

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

Tcf1 and Lef1 Are Required for the Immunosuppressive Function of Regulatory T Cells

Zfp335 establishes eTreg lineage and neonatal immune tolerance by targeting Hadha-mediated fatty acid oxidation

CXXC-finger protein 1 associates with FOXP3 to stabilize homeostasis and suppressive functions of regulatory T cells

Ubiquitination Signals Critical to Regulatory T Cell Development and Function

ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut

Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis

FOXP3 exon 2 controls T reg stability and autoimmunity